1[1]Tsujimoto Y, Finger LR, Yunis J, Nowell PC, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18)chromosome translocation[J]. Science,1984,226 (4678):1 097-1 099.
2[2]Miyashita T, Reed JC. bcl-2 gene transfer increases relative resistance of S49.1 and WEH17. 2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs[J]. Cancer Res,1992,52(19):5 407-5 411.
3[3]Cain K, Bratton SB, Langlais C, et al. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDaapoptosome complexes[J].J Biol Chem,2000,275(9):6 067-6 070.
4[4]Jacobson MD. Apoptosis: Bcl-2-reiated proteins get connected[J]. Curr Biol,2003,7(5):277-281.
5[5]Krajewski S, Tanaka S, Takayama S, et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes[J]. Cancer Res,2002,62 (19):4 701-4 714.
6[6]Allsopp TE, Wyatt S, Paterson HF, et al. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis[J].Cell,1993,73(2):295-307.
7[7]Rmashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling[J].Nature,1999,401(6 748):86-90.
8[8]De Moissac D,Gurevich RM, Zheng H, et al. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes[J]. J Mol Cell Cardiol,2000,32(1):53-63.
9[9]Kirshenbaum LA. Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventriCular myocytes[J]. Clin Invest Med,2000,23(5):322-330.
10[10]Ozes ON,Mayo LD,Gustin JA, et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase [J]. Nature,1999,401(6 748):82-85.
